Literature DB >> 11135668

Mechanism-based design of a protein kinase inhibitor.

K Parang1, J H Till, A J Ablooglu, R A Kohanski, S R Hubbard, P A Cole.   

Abstract

Protein kinase inhibitors have applications as anticancer therapeutic agents and biological tools in cell signaling. Based on a phosphoryl transfer mechanism involving a dissociative transition state, a potent and selective bisubstrate inhibitor for the insulin receptor tyrosine kinase was synthesized by linking ATPgammaS to a peptide substrate analog via a two-carbon spacer. The compound was a high affinity competitive inhibitor against both nucleotide and peptide substrates and showed a slow off-rate. A crystal structure of this inhibitor bound to the tyrosine kinase domain of the insulin receptor confirmed the key design features inspired by a dissociative transition state, and revealed that the linker takes part in the octahedral coordination of an active site Mg2+. These studies suggest a general strategy for the development of selective protein kinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135668     DOI: 10.1038/83028

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  47 in total

Review 1.  Catalytic mechanisms and regulation of protein kinases.

Authors:  Zhihong Wang; Philip A Cole
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

2.  Mechanistic studies of beta-arylsulfotransferase IV.

Authors:  Eli Chapman; Marian C Bryan; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

3.  Mapping protein pockets through their potential small-molecule binding volumes: QSCD applied to biological protein structures.

Authors:  Keith Mason; Nehal M Patel; Aric Ledel; Ciamac C Moallemi; Edward A Wintner
Journal:  J Comput Aided Mol Des       Date:  2004-01       Impact factor: 3.686

4.  Directed discovery of bivalent peptide ligands to an SH3 domain.

Authors:  Monique R Ferguson; Xiuzhen Fan; Munia Mukherjee; Jinquan Luo; Raza Khan; Josephine C Ferreon; Vincent J Hilser; Robert E Shope; Robert O Fox
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

5.  Selection of cyclic-peptide inhibitors targeting Aurora kinase A: problems and solutions.

Authors:  Carolyn D Shomin; Elizabeth Restituyo; Kurt J Cox; Indraneel Ghosh
Journal:  Bioorg Med Chem       Date:  2011-09-29       Impact factor: 3.641

6.  Acquisition of a "Group A"-selective Src kinase inhibitor via a global targeting strategy.

Authors:  Jung-Mi Hah; Vyas Sharma; Haishan Li; David S Lawrence
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

7.  Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor.

Authors:  Brad P Barnett; Yousang Hwang; Martin S Taylor; Henriette Kirchner; Paul T Pfluger; Vincent Bernard; Yu-yi Lin; Erin M Bowers; Chandrani Mukherjee; Woo-Jin Song; Patti A Longo; Daniel J Leahy; Mehboob A Hussain; Matthias H Tschöp; Jef D Boeke; Philip A Cole
Journal:  Science       Date:  2010-11-18       Impact factor: 47.728

Review 8.  Substrate and docking interactions in serine/threonine protein kinases.

Authors:  Elizabeth J Goldsmith; Radha Akella; Xiaoshan Min; Tianjun Zhou; John M Humphreys
Journal:  Chem Rev       Date:  2007-10-19       Impact factor: 60.622

Review 9.  Understanding and exploiting substrate recognition by protein kinases.

Authors:  Benjamin E Turk
Journal:  Curr Opin Chem Biol       Date:  2008-03-07       Impact factor: 8.822

10.  Mapping RNAPII CTD Phosphorylation Reveals That the Identity and Modification of Seventh Heptad Residues Direct Tyr1 Phosphorylation.

Authors:  Nathaniel T Burkholder; Sarah N Sipe; Edwin E Escobar; Mukeshkumar Venkatramani; Seema Irani; Wanjie Yang; Haoyi Wu; Wendy M Matthews; Jennifer S Brodbelt; Yan Zhang
Journal:  ACS Chem Biol       Date:  2019-10-07       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.